Skip to content

Evaluation of Laser Therapy in the Prevention and Treatment of Oral Irritations Due to Cancer Treatment

Evaluation of the Low Intensity Laser in the Prevention and Treatment of Oral Mucositis: Double Blind Randomized Clinical Trial

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
REBEC
Registry ID
RBR-92md93
Enrollment
Unknown
Registered
2017-01-18
Start date
2016-08-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Oral Mucositis

Interventions

E02774500
As a result of the sample calculation, the experimental and control subgroups should have 22 participants, consequently 44 in each group and a total sample of 132 patients.In the experimental subgroup
Radiation

Sponsors

Universidade Federal de Pernambuco
Lead Sponsor
Universidade Federal de Pernambuco
Collaborator

Eligibility

Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: Group 1: Patients with head and neck neoplasms undergoing radiotherapy;Group 2: Patients with head and neck neoplasms undergoing radiochemotherapy;Group 3: Patients with neoplasias of the gastrointestinal tract under chemotherapeutic treatment (Fluorpyrimidine).

Exclusion criteria

Exclusion criteria: Patients younger than 18 years;Presence of oral ulcerations or erosions;Cognitive deficits;Simultaneous participation in another clinical study;In long-term treatment with photosensitizing agents.Difficulty opening the mouth, such as trismus or maxillo-mandibular block.

Design outcomes

Primary

MeasureTime frame
Lower prevalence of oral mucositis, comparing the proportions between the experimental and control subgroup, a significance of 5% and a 95% confidence interval will be adopted. According to normality tests, parametric or non-parametric tests will be adopted To compare the proportions.

Secondary

MeasureTime frame
Minor severity and pain of Oral Mucositis. The degree of Oral Mucositis will be assessed according to World Health Organization classification criteria and in relation to oral pain, patients will be assessed subjectively according to a Visual Analogue Scale. According to normality tests, parametric or non-parametric tests will be used to compare the means, a significance of 5% and a confidence interval of 95% will be adopted.

Countries

Brazil

Contacts

Public ContactJanaina Cavalcanti

Universidade Federal de Pernambuco

janainaxcavalcanti@gmail.com+55(81)8194091979

Outcome results

None listed

Source: REBEC (via WHO ICTRP)